Tier 1 — highest
Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial
Nature and science of sleep
2025
17:2027-2040
Bibliography
- PubMed
- PMID 40918053
- PubMed Central
- PMC12412596
- Trial registry
- View on ClinicalTrials.gov Registered trial — results not yet published in a peer-reviewed journal.
- Funding
- Support is recorded from Leibniz University Hannover. See the original publication for grant and material-support details.
- Competing interests
- One author reports directing a contract research organization and receiving nutraceutical-industry research funding and presentation honoraria; the other authors reported no conflicts.
Study snapshot
| Design | Randomized, double-blind, placebo-controlled trial |
|---|---|
| Model | Human participants |
| Sample | 155 adults aged 18–65 reporting poor sleep |
| Intervention | Magnesium bisglycinate providing 250 mg/day elemental magnesium or placebo |
| Duration | 4 weeks |
| Endpoints | Insomnia Severity Index; Psychological questionnaires |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
- Magnesium L-Threonate for Sleep: What the Trials Actually FoundWhat magnesium L-threonate sleep trials found: doses, timing, wearable results, daytime function, corrections and comparison with glycinate.Read analysis
- Magnesium L-Threonate vs Glycinate: Evidence, Dose and CostL-threonate versus glycinate for sleep, cognition and intake: compare trials, elemental doses, tolerability, cost and combining forms.Read analysis
- Magnesium L-Threonate: Benefits, Dosage and Human ResearchCompare human magnesium L-threonate trials for cognition and sleep, including doses, effect sizes, formulations and research limitations.Read analysis
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified
Biohack Blueprint Research